Inspection Record

Globyz Pharma — Health Canada Inspection Findings

Health CanadaInspected 2024-10-23 7 findingsTraining and personnelComplaint and recall handlingOther quality systemEquipment and facility

View the regulator's official source The source document is always the basis for judgement.

Findings

1Training and personnel

The job descriptions for personnel, the authority given to personnel, and/or the delegation of duties was inadequate and/or undocumented.

2Complaint and recall handling

The written procedures for recalls were inadequate.

3Other quality system

The implementation of a self-inspection program was inadequate.

4Equipment and facility

The maintenance of records was inadequate.

5Equipment and facility

The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.

6Other quality system

The handling of standard operating procedures for good manufacturing practices was inadequate.

7Equipment and facility

The maintenance of the premises was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2024-10-23. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Globyz Pharma company profile — full history Health Canada documents, 2024 Go to Findings search